DK2046831T3 - Hidtil ukendte, multivalente immunoglobuliner - Google Patents
Hidtil ukendte, multivalente immunoglobulinerInfo
- Publication number
- DK2046831T3 DK2046831T3 DK07718518.9T DK07718518T DK2046831T3 DK 2046831 T3 DK2046831 T3 DK 2046831T3 DK 07718518 T DK07718518 T DK 07718518T DK 2046831 T3 DK2046831 T3 DK 2046831T3
- Authority
- DK
- Denmark
- Prior art keywords
- new multivalent
- multivalent immunoglobulins
- immunoglobulins
- new
- multivalent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0114706A AT503889B1 (de) | 2006-07-05 | 2006-07-05 | Multivalente immunglobuline |
| PCT/AT2007/000313 WO2008003103A2 (en) | 2006-07-05 | 2007-06-26 | Novel multivalent immunoglobulins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2046831T3 true DK2046831T3 (da) | 2012-05-29 |
Family
ID=38720179
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07718518.9T DK2046831T3 (da) | 2006-07-05 | 2007-06-26 | Hidtil ukendte, multivalente immunoglobuliner |
| DK11194316.3T DK2463302T3 (da) | 2006-07-05 | 2007-06-26 | Multivalente immunglobuliner modificeret i den strukturelle loop-region |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11194316.3T DK2463302T3 (da) | 2006-07-05 | 2007-06-26 | Multivalente immunglobuliner modificeret i den strukturelle loop-region |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20100048877A1 (da) |
| EP (2) | EP2463302B1 (da) |
| JP (3) | JP5924751B2 (da) |
| CN (3) | CN101522712A (da) |
| AT (2) | AT503889B1 (da) |
| DK (2) | DK2046831T3 (da) |
| ES (2) | ES2539593T3 (da) |
| HU (1) | HUE025035T2 (da) |
| PL (2) | PL2463302T3 (da) |
| PT (2) | PT2463302E (da) |
| SI (2) | SI2046831T1 (da) |
| WO (1) | WO2008003103A2 (da) |
Families Citing this family (118)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4937138B2 (ja) | 2005-01-05 | 2012-05-23 | エフ−シュタール・ビオテヒノロギシェ・フォルシュングス−ウント・エントヴィックルングスゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 相補性決定領域とは異なる分子の領域に設計された結合性を持つ合成免疫グロブリンドメイン |
| AT503889B1 (de) | 2006-07-05 | 2011-12-15 | Star Biotechnologische Forschungs Und Entwicklungsges M B H F | Multivalente immunglobuline |
| AT503902B1 (de) * | 2006-07-05 | 2008-06-15 | F Star Biotech Forsch & Entw | Verfahren zur manipulation von immunglobulinen |
| CN101835802B (zh) | 2007-06-01 | 2014-04-09 | 马里兰大学巴尔的摩分校 | 免疫球蛋白恒定区Fc受体结合剂 |
| ES2975748T3 (es) * | 2007-06-26 | 2024-07-12 | F Star Therapeutics Ltd | Presentación de agentes de unión |
| EP2195341B1 (en) | 2007-09-26 | 2017-03-22 | UCB Biopharma SPRL | Dual specificity antibody fusions |
| US8574577B2 (en) | 2008-01-03 | 2013-11-05 | The Scripps Research Institute | VEGF antibodies comprising modular recognition domains |
| US8454960B2 (en) | 2008-01-03 | 2013-06-04 | The Scripps Research Institute | Multispecific antibody targeting and multivalency through modular recognition domains |
| ES2689274T3 (es) | 2008-01-03 | 2018-11-13 | The Scripps Research Institute | Dirección de anticuerpos mediante un dominio de reconocimiento modular |
| US8557242B2 (en) | 2008-01-03 | 2013-10-15 | The Scripps Research Institute | ERBB2 antibodies comprising modular recognition domains |
| US8557243B2 (en) | 2008-01-03 | 2013-10-15 | The Scripps Research Institute | EFGR antibodies comprising modular recognition domains |
| CN101977932B (zh) * | 2008-01-31 | 2014-09-03 | 美国政府健康及人类服务部 | 工程化抗体恒定结构域分子 |
| EP2113255A1 (en) | 2008-05-02 | 2009-11-04 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Cytotoxic immunoglobulin |
| EA201100527A1 (ru) | 2008-09-26 | 2011-10-31 | Юсб Фарма С.А. | Биологические продукты |
| CN102471375A (zh) * | 2009-07-09 | 2012-05-23 | F-斯塔生物技术研究和发展有限公司 | 稳定的免疫球蛋白恒定结构域 |
| US9493578B2 (en) | 2009-09-02 | 2016-11-15 | Xencor, Inc. | Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens |
| EP2407487A1 (en) | 2010-07-14 | 2012-01-18 | F-Star Biotechnologische Forschungs - und Entwicklungsges. M.B.H. | Multispecific modular antibody |
| US20120100166A1 (en) | 2010-07-15 | 2012-04-26 | Zyngenia, Inc. | Ang-2 Binding Complexes and Uses Thereof |
| AU2011282579B2 (en) | 2010-07-28 | 2014-10-23 | Gliknik Inc. | Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions |
| AU2011283694B2 (en) | 2010-07-29 | 2017-04-13 | Xencor, Inc. | Antibodies with modified isoelectric points |
| JP2014500879A (ja) | 2010-11-16 | 2014-01-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｂｃｍａ発現に相関性を有する疾患を治療する因子及び方法 |
| WO2012109553A2 (en) | 2011-02-11 | 2012-08-16 | Research Corporation Technologies | Ch2 domain template molecules derived from rational grafting of donor loops onto ch2 scaffolds |
| CN106432506A (zh) | 2011-05-24 | 2017-02-22 | 泽恩格尼亚股份有限公司 | 多价和单价多特异性复合物及其用途 |
| EP2546268A1 (en) | 2011-07-13 | 2013-01-16 | F-Star Biotechnologische Forschungs - und Entwicklungsges. M.B.H. | Internalising immunoglobulin |
| PE20141521A1 (es) * | 2011-08-23 | 2014-10-25 | Roche Glycart Ag | Moleculas biespecificas de union a antigeno activadoras de celulas t |
| US10851178B2 (en) | 2011-10-10 | 2020-12-01 | Xencor, Inc. | Heterodimeric human IgG1 polypeptides with isoelectric point modifications |
| US20140370012A1 (en) * | 2012-01-27 | 2014-12-18 | Gliknik Inc. | Fusion proteins comprising igg2 hinge domains |
| JP6628966B2 (ja) * | 2012-06-14 | 2020-01-15 | 中外製薬株式会社 | 改変されたＦｃ領域を含む抗原結合分子 |
| US9683044B2 (en) | 2012-08-20 | 2017-06-20 | Gliknik Inc. | Molecules with antigen binding and polyvalent FC gamma receptor binding activity |
| US10766960B2 (en) | 2012-12-27 | 2020-09-08 | Chugai Seiyaku Kabushiki Kaisha | Heterodimerized polypeptide |
| US9605084B2 (en) | 2013-03-15 | 2017-03-28 | Xencor, Inc. | Heterodimeric proteins |
| US10131710B2 (en) | 2013-01-14 | 2018-11-20 | Xencor, Inc. | Optimized antibody variable regions |
| US11053316B2 (en) | 2013-01-14 | 2021-07-06 | Xencor, Inc. | Optimized antibody variable regions |
| US10968276B2 (en) | 2013-03-12 | 2021-04-06 | Xencor, Inc. | Optimized anti-CD3 variable regions |
| US10487155B2 (en) | 2013-01-14 | 2019-11-26 | Xencor, Inc. | Heterodimeric proteins |
| US9701759B2 (en) | 2013-01-14 | 2017-07-11 | Xencor, Inc. | Heterodimeric proteins |
| US10738132B2 (en) | 2013-01-14 | 2020-08-11 | Xencor, Inc. | Heterodimeric proteins |
| WO2014113510A1 (en) | 2013-01-15 | 2014-07-24 | Xencor, Inc. | Rapid clearance of antigen complexes using novel antibodies |
| US10519242B2 (en) | 2013-03-15 | 2019-12-31 | Xencor, Inc. | Targeting regulatory T cells with heterodimeric proteins |
| US10106624B2 (en) | 2013-03-15 | 2018-10-23 | Xencor, Inc. | Heterodimeric proteins |
| EP3421495A3 (en) | 2013-03-15 | 2019-05-15 | Xencor, Inc. | Modulation of t cells with bispecific antibodies and fc fusions |
| EP3424530A1 (en) | 2013-03-15 | 2019-01-09 | Zyngenia, Inc. | Multivalent and monovalent multispecific complexes and their uses |
| US10858417B2 (en) | 2013-03-15 | 2020-12-08 | Xencor, Inc. | Heterodimeric proteins |
| JPWO2015068847A1 (ja) | 2013-11-11 | 2017-03-09 | 中外製薬株式会社 | 改変された抗体可変領域を含む抗原結合分子 |
| BR112016022385A2 (pt) | 2014-03-28 | 2018-06-19 | Xencor, Inc | anticorpos específicos que se ligam a cd38 e cd3 |
| TWI742423B (zh) | 2014-05-29 | 2021-10-11 | 美商宏觀基因股份有限公司 | 特異性結合多種癌症抗原的三特異性結合分子和其使用方法 |
| TWI693232B (zh) | 2014-06-26 | 2020-05-11 | 美商宏觀基因股份有限公司 | 與pd-1和lag-3具有免疫反應性的共價結合的雙抗體和其使用方法 |
| SG11201701189TA (en) | 2014-08-15 | 2017-03-30 | Merck Patent Gmbh | Sirp-alpha immunoglobulin fusion proteins |
| EA201790719A1 (ru) | 2014-09-26 | 2017-07-31 | Макродженикс, Инк. | Биспецифические моновалентные диатела, которые способны связывать cd19 и cd3, а также их применения |
| TWI831044B (zh) | 2014-11-11 | 2024-02-01 | 日商中外製藥股份有限公司 | 抗原結合分子、包含抗原結合分子的醫藥組合物以及製造及選擇抗原結合分子之方法 |
| AU2015353416C1 (en) | 2014-11-26 | 2022-01-27 | Xencor, Inc. | Heterodimeric antibodies that bind CD3 and CD38 |
| US10259887B2 (en) | 2014-11-26 | 2019-04-16 | Xencor, Inc. | Heterodimeric antibodies that bind CD3 and tumor antigens |
| CN110894240B (zh) | 2014-11-26 | 2022-04-15 | 森科股份有限公司 | 结合cd3和肿瘤抗原的异二聚体抗体 |
| US10982008B2 (en) * | 2014-12-05 | 2021-04-20 | Merck Patent Gmbh | Domain-exchanged antibody |
| WO2016105450A2 (en) | 2014-12-22 | 2016-06-30 | Xencor, Inc. | Trispecific antibodies |
| JP6602875B2 (ja) | 2015-01-26 | 2019-11-06 | マクロジェニクス，インコーポレーテッド | Ｄｒ５結合ドメインを含む多価分子 |
| WO2016141387A1 (en) | 2015-03-05 | 2016-09-09 | Xencor, Inc. | Modulation of t cells with bispecific antibodies and fc fusions |
| TWI773646B (zh) | 2015-06-08 | 2022-08-11 | 美商宏觀基因股份有限公司 | 結合lag-3的分子和其使用方法 |
| PL3328419T3 (pl) | 2015-07-30 | 2021-12-27 | Macrogenics, Inc. | Cząsteczki wiążące pd-1 i sposoby ich zastosowania |
| RU2731202C2 (ru) | 2015-10-08 | 2020-08-31 | Макродженикс, Инк. | Комбинированная терапия для лечения рака |
| JP7058219B2 (ja) | 2015-12-07 | 2022-04-21 | ゼンコア インコーポレイテッド | Ｃｄ３及びｐｓｍａに結合するヘテロ二量体抗体 |
| KR102424513B1 (ko) | 2015-12-14 | 2022-07-25 | 마크로제닉스, 인크. | Pd-1 및 ctla-4과의 면역반응성을 가진 이중특이적 분자, 및 이것의 사용 방법 |
| TW201730212A (zh) | 2016-02-17 | 2017-09-01 | 宏觀基因股份有限公司 | Ｒｏｒ１－結合分子及其使用方法 |
| MX2018012433A (es) | 2016-04-15 | 2019-03-01 | Macrogenics Inc | Moleculas de union b7-h3 novedosas, conjugados anticuerpo-farmaco de los mismos y metodos de uso de los mismos. |
| GB2550114A (en) | 2016-05-03 | 2017-11-15 | Kymab Ltd | Methods, regimens, combinations & antagonists |
| CA3026420A1 (en) | 2016-06-07 | 2017-12-14 | Gliknik Inc. | Cysteine-optimized stradomers |
| CA3026151A1 (en) | 2016-06-14 | 2017-12-21 | Xencor, Inc. | Bispecific checkpoint inhibitor antibodies |
| EP3471753A1 (en) | 2016-06-20 | 2019-04-24 | Kymab Limited | Anti-pd-l1 and il-2 cytokines |
| EP3475304B1 (en) | 2016-06-28 | 2022-03-23 | Xencor, Inc. | Heterodimeric antibodies that bind somatostatin receptor 2 |
| CN116640214A (zh) | 2016-08-09 | 2023-08-25 | 科马布有限公司 | 分离抗体及其应用 |
| US10793632B2 (en) | 2016-08-30 | 2020-10-06 | Xencor, Inc. | Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors |
| PE20191034A1 (es) | 2016-10-14 | 2019-08-05 | Xencor Inc | Proteinas de fusion heterodimericas biespecificas que contienen proteinas de fusion fc il-15/il-15r y fragmentos de anticuerpo pd-1 |
| AU2017371179B2 (en) | 2016-12-09 | 2022-07-14 | Gliknik Inc. | Manufacturing optimization of GL-2045, a multimerizing stradomer |
| AR110424A1 (es) | 2016-12-23 | 2019-03-27 | Macrogenics Inc | Moléculas de unión a adam9 y métodos de uso de las mismas |
| EP3574017A1 (en) | 2017-01-27 | 2019-12-04 | Kymab Limited | Anti-opg antibodies |
| DK3583120T5 (da) | 2017-02-17 | 2024-09-02 | Denali Therapeutics Inc | Modificerede transferrinreceptorbindende polypeptider |
| CN110325209A (zh) | 2017-02-24 | 2019-10-11 | 宏观基因有限公司 | 能够结合cd137和肿瘤抗原的双特异性结合分子及其用途 |
| EP3415527A1 (de) | 2017-06-14 | 2018-12-19 | Technische Universität Dresden | Verwendung der extrazellulären domäne des transferrinrezeptor 2 zur diagnostik und behandlung von primär und sekundär sklerosierenden erkrankungen |
| GB201709970D0 (en) | 2017-06-22 | 2017-08-09 | Kymab Ltd | Bispecific antigen-binding molecules |
| AU2018291497A1 (en) | 2017-06-30 | 2020-01-16 | Xencor, Inc. | Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15Ra and antigen binding domains |
| AU2018312075A1 (en) | 2017-07-31 | 2020-02-20 | Osaka University | Highly versatile method of presenting cyclic peptide on protein structure |
| CA3076369A1 (en) | 2017-10-02 | 2019-04-11 | Denali Therapeutics Inc. | Fusion proteins comprising enzyme replacement therapy enzymes |
| US10981992B2 (en) | 2017-11-08 | 2021-04-20 | Xencor, Inc. | Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors |
| EP3706793A1 (en) | 2017-11-08 | 2020-09-16 | Xencor, Inc. | Bispecific and monospecific antibodies using novel anti-pd-1 sequences |
| TW201938194A (zh) | 2017-12-05 | 2019-10-01 | 日商中外製藥股份有限公司 | 包含結合cd3及cd137的改變的抗體可變區之抗原結合分子 |
| MX2020006155A (es) | 2017-12-12 | 2020-08-13 | Macrogenics Inc | Moleculas de union a cd-16 biespecificas y su uso en el tratamiento de enfermedades. |
| EP3728314A1 (en) | 2017-12-19 | 2020-10-28 | Kymab Limited | Bispecific antibody for icos and pd-l1 |
| JP2021506291A (ja) | 2017-12-19 | 2021-02-22 | ゼンコア インコーポレイテッド | 改変されたｉｌ−２ ｆｃ融合タンパク質 |
| US11685781B2 (en) | 2018-02-15 | 2023-06-27 | Macrogenics, Inc. | Variant CD3-binding domains and their use in combination therapies for the treatment of disease |
| CA3096052A1 (en) | 2018-04-04 | 2019-10-10 | Xencor, Inc. | Heterodimeric antibodies that bind fibroblast activation protein |
| US10633458B2 (en) | 2018-04-10 | 2020-04-28 | Y-Biologics Inc. | Cell engaging binding molecules |
| CA3097741A1 (en) | 2018-04-18 | 2019-10-24 | Xencor, Inc. | Tim-3 targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and tim-3 antigen binding domains |
| US11524991B2 (en) | 2018-04-18 | 2022-12-13 | Xencor, Inc. | PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins and PD-1 antigen binding domains and uses thereof |
| CA3100818A1 (en) | 2018-06-13 | 2019-12-19 | Kymab Limited | Treatments etc |
| GB201811408D0 (en) | 2018-07-12 | 2018-08-29 | F Star Beta Ltd | CD137 Binding Molecules |
| GB201811410D0 (en) * | 2018-07-12 | 2018-08-29 | F Star Beta Ltd | OX40 Binding molecules |
| GB201815629D0 (en) | 2018-09-25 | 2018-11-07 | Kymab Ltd | Antagonists |
| SG11202103192RA (en) | 2018-10-03 | 2021-04-29 | Xencor Inc | Il-12 heterodimeric fc-fusion proteins |
| GB201820687D0 (en) | 2018-12-19 | 2019-01-30 | Kymab Ltd | Antagonists |
| US11739160B2 (en) | 2018-12-24 | 2023-08-29 | Sanofi | PseudoFab-based multispecific binding proteins |
| JP2022523946A (ja) | 2019-03-01 | 2022-04-27 | ゼンコア インコーポレイテッド | Ｅｎｐｐ３およびｃｄ３に結合するヘテロ二量体抗体 |
| GB201905552D0 (en) | 2019-04-18 | 2019-06-05 | Kymab Ltd | Antagonists |
| KR102505383B1 (ko) | 2020-03-31 | 2023-03-02 | 추가이 세이야쿠 가부시키가이샤 | Dll3 표적 다중 특이성 항원 결합 분자 및 그의 사용 |
| WO2021231976A1 (en) | 2020-05-14 | 2021-11-18 | Xencor, Inc. | Heterodimeric antibodies that bind prostate specific membrane antigen (psma) and cd3 |
| GB202007099D0 (en) | 2020-05-14 | 2020-07-01 | Kymab Ltd | Tumour biomarkers for immunotherapy |
| WO2022010798A1 (en) | 2020-07-06 | 2022-01-13 | Kiromic BioPharma, Inc. | Mesothelin isoform binding molecules and chimeric pd1 receptor molecules, cells containing the same and uses thereof |
| JP2023538891A (ja) | 2020-08-19 | 2023-09-12 | ゼンコア インコーポレイテッド | 抗ｃｄ２８組成物 |
| GB202017058D0 (en) | 2020-10-27 | 2020-12-09 | Kymab Ltd | Antibodies and uses thereof |
| WO2022108627A1 (en) | 2020-11-18 | 2022-05-27 | Kiromic Biopharma, Inc.Kiromic Biopharma, Inc. | Gamma-delta t cell manufacturing processes and chimeric pd1 receptor molecules |
| GB202101125D0 (en) | 2021-01-27 | 2021-03-10 | Kymab Ltd | Antibodies and uses thereof |
| AU2022232375A1 (en) | 2021-03-09 | 2023-09-21 | Xencor, Inc. | Heterodimeric antibodies that bind cd3 and cldn6 |
| KR20230154311A (ko) | 2021-03-10 | 2023-11-07 | 젠코어 인코포레이티드 | Cd3 및 gpc3에 결합하는 이종이량체 항체 |
| EP4326323A1 (en) * | 2021-04-19 | 2024-02-28 | Janssen Biotech, Inc. | Molecules with engineered antibody constant region variants |
| GB202107372D0 (en) | 2021-05-24 | 2021-07-07 | Petmedix Ltd | Animal models and therapeutics molecules |
| GB202209247D0 (en) | 2022-06-23 | 2022-08-10 | Petmedix Ltd | Animal models and therapeutic molecules |
| GB202217978D0 (en) | 2022-11-30 | 2023-01-11 | Petmedix Ltd | Rodents expressing a common light chain |
| US20240199761A1 (en) | 2022-12-19 | 2024-06-20 | Astrazeneca Ab | Treatment of autoimmune disease |
| US20240294651A1 (en) | 2023-01-30 | 2024-09-05 | Kymab Limited | Antibodies |
Family Cites Families (104)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1985003947A1 (en) | 1984-03-01 | 1985-09-12 | The Board Of Trustees Of The Leland Stanford Jr. U | T-cell receptor-specific for antigen polypeptides and related polynucleotides |
| US6492107B1 (en) | 1986-11-20 | 2002-12-10 | Stuart Kauffman | Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
| DE3590766T (da) | 1985-03-30 | 1987-04-23 | ||
| US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| EP0511308B2 (en) * | 1989-12-27 | 2003-07-09 | Centocor, Inc. | Chimeric immunoglobulin for cd4 receptors |
| JP3283041B2 (ja) * | 1990-07-13 | 2002-05-20 | 学校法人藤田学園 | 人工抗体 |
| DK0564531T3 (da) | 1990-12-03 | 1998-09-28 | Genentech Inc | Berigelsesfremgangsmåde for variantproteiner med ændrede bindingsegenskaber |
| ES2315612T3 (es) | 1991-04-10 | 2009-04-01 | The Scripps Research Institute | Genotecas de receptores heterodimericos usando fagemidos. |
| US5270170A (en) | 1991-10-16 | 1993-12-14 | Affymax Technologies N.V. | Peptide library and screening method |
| US5395750A (en) | 1992-02-28 | 1995-03-07 | Hoffmann-La Roche Inc. | Methods for producing proteins which bind to predetermined antigens |
| EP0640130B1 (en) | 1992-05-08 | 1998-04-15 | Creative Biomolecules, Inc. | Chimeric multivalent protein analogues and methods of use thereof |
| EP1550729B1 (en) | 1992-09-25 | 2009-05-27 | Avipep Pty Limited | Target binding polypeptide comprising an IG-like VL domain linked to an IG-like VH domain |
| US5536814A (en) * | 1993-09-27 | 1996-07-16 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
| DE69522216T2 (de) * | 1994-05-13 | 2002-05-02 | Biovation Ltd | Zielzellen-bindende chimäre Peptide |
| GB9501079D0 (en) | 1995-01-19 | 1995-03-08 | Bioinvent Int Ab | Activation of T-cells |
| AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
| US5783186A (en) | 1995-12-05 | 1998-07-21 | Amgen Inc. | Antibody-induced apoptosis |
| US6361974B1 (en) | 1995-12-07 | 2002-03-26 | Diversa Corporation | Exonuclease-mediated nucleic acid reassembly in directed evolution |
| US6352842B1 (en) | 1995-12-07 | 2002-03-05 | Diversa Corporation | Exonucease-mediated gene assembly in directed evolution |
| US6358709B1 (en) * | 1995-12-07 | 2002-03-19 | Diversa Corporation | End selection in directed evolution |
| EP0904107B1 (en) | 1996-03-18 | 2004-10-20 | Board Of Regents, The University Of Texas System | Immunoglobin-like domains with increased half lives |
| US6696251B1 (en) | 1996-05-31 | 2004-02-24 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| EP0977886A4 (en) | 1997-03-07 | 2002-10-23 | Sunol Molecular Corp | FUSION PROTEINS, WHICH CONTAIN A BACTERIOPHAGE ENVELOPE PROTEIN AND A SINGLE CHAIN T-CELL RECEPTOR |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| CA2293632C (en) | 1997-06-12 | 2011-11-29 | Research Corporation Technologies, Inc. | Artificial antibody polypeptides |
| GB9722131D0 (en) | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| DK2180007T4 (da) | 1998-04-20 | 2017-11-27 | Roche Glycart Ag | Glycosyleringsteknik for antistoffer til forbedring af antistofafhængig cellecytotoxicitet |
| US6180343B1 (en) | 1998-10-08 | 2001-01-30 | Rigel Pharmaceuticals, Inc. | Green fluorescent protein fusions with random peptides |
| US6818418B1 (en) | 1998-12-10 | 2004-11-16 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| AU3210100A (en) | 1999-01-19 | 2000-08-01 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| CA2364997A1 (en) * | 1999-03-05 | 2000-09-08 | Maxygen, Inc. | Encryption of traits using split gene sequences |
| US6472147B1 (en) | 1999-05-25 | 2002-10-29 | The Scripps Research Institute | Methods for display of heterodimeric proteins on filamentous phage using pVII and pIX, compositions, vectors and combinatorial libraries |
| DE60028970T2 (de) | 1999-07-02 | 2007-02-15 | Genentech Inc., San Francisco | An her2 bindende peptidverbindungen |
| EP2336775A3 (en) | 1999-12-06 | 2013-03-20 | Board Of Trustees Of The University Of Illinois | High affinity TCR proteins and methods |
| EP1118661A1 (en) | 2000-01-13 | 2001-07-25 | Het Nederlands Kanker Instituut | T cell receptor libraries |
| JP2003274960A (ja) | 2000-02-03 | 2003-09-30 | Japan Science & Technology Corp | 可溶性ｔ細胞受容体タンパク質およびその作成方法 |
| EP1259601A2 (en) | 2000-02-22 | 2002-11-27 | Ahuva Nissim | Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof |
| AU2001243670A1 (en) | 2000-03-20 | 2001-10-03 | Maxygen, Inc. | Method for generating recombinant dna molecules in complex mixtures |
| JP2003533187A (ja) * | 2000-05-03 | 2003-11-11 | アムジエン・インコーポレーテツド | 治療薬としてのＦｃドメインを含む修飾ペプチド |
| AU2001261628A1 (en) | 2000-05-16 | 2001-11-26 | Euroceltique S.A. | Cd28 synthebody for the modulation of immune responses |
| US20020103345A1 (en) | 2000-05-24 | 2002-08-01 | Zhenping Zhu | Bispecific immunoglobulin-like antigen binding proteins and method of production |
| US6406863B1 (en) | 2000-06-23 | 2002-06-18 | Genetastix Corporation | High throughput generation and screening of fully human antibody repertoire in yeast |
| AU2001273559A1 (en) | 2000-07-18 | 2002-01-30 | Enchira Biotechnology Corporation | Methods of ligation mediated chimeragenesis utilizing populations of scaffold and donor nucleic acids |
| AU2001283496A1 (en) * | 2000-07-25 | 2002-02-05 | Immunomedics, Inc. | Multivalent target binding protein |
| JP2002058479A (ja) | 2000-08-14 | 2002-02-26 | Canon Inc | 構造認識アミノ酸配列の取得方法 |
| AU2002213251B2 (en) * | 2000-10-16 | 2007-06-14 | Bristol-Myers Squibb Company | Protein scaffolds for antibody mimics and other binding proteins |
| US20040082508A1 (en) | 2000-11-08 | 2004-04-29 | Henry Yue | Secreted proteins |
| GB0029407D0 (en) | 2000-12-01 | 2001-01-17 | Affitech As | Product |
| ATE489395T1 (de) | 2000-12-12 | 2010-12-15 | Medimmune Llc | Moleküle mit längeren halbwertszeiten, zusammensetzungen und deren verwendung |
| AU2002246733B2 (en) | 2000-12-19 | 2007-09-20 | Altor Bioscience Corporation | Transgenic animals comprising a humanized immune system |
| IL141539A0 (en) | 2001-02-20 | 2002-03-10 | Yeda Res & Dev | Dna molecules and cells transfected therewith |
| ATE472609T1 (de) | 2001-04-26 | 2010-07-15 | Amgen Mountain View Inc | Kombinatorische bibliotheken von monomerdomänen |
| US20030157561A1 (en) | 2001-11-19 | 2003-08-21 | Kolkman Joost A. | Combinatorial libraries of monomer domains |
| EP1281757A1 (en) | 2001-07-31 | 2003-02-05 | Direvo Biotech AG | Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids |
| CA2457652C (en) | 2001-08-31 | 2012-08-07 | Avidex Limited | Soluble t cell receptor |
| CA2462113C (en) | 2001-10-01 | 2013-01-29 | Dyax Corp. | Multi-chain eukaryotic display vectors and uses thereof |
| WO2003034995A2 (en) * | 2001-10-22 | 2003-05-01 | The Scripps Research Institute | Integrin targeting compounds |
| US20040043424A1 (en) | 2001-11-15 | 2004-03-04 | Baughn Mariah R | Immunoglobulin superfamily proteins |
| EP2075256A2 (en) * | 2002-01-14 | 2009-07-01 | William Herman | Multispecific binding molecules |
| US20040063924A1 (en) | 2002-01-28 | 2004-04-01 | Y Tom Tang | Secreted proteins |
| US20030157091A1 (en) | 2002-02-14 | 2003-08-21 | Dyax Corporation | Multi-functional proteins |
| CA2476764A1 (en) | 2002-02-19 | 2003-08-28 | Syntherica Corporation | Compositions and methods for surrogate antibody modulation of an immune response and transport |
| US7317091B2 (en) | 2002-03-01 | 2008-01-08 | Xencor, Inc. | Optimized Fc variants |
| US20040132101A1 (en) | 2002-09-27 | 2004-07-08 | Xencor | Optimized Fc variants and methods for their generation |
| JP2005526506A (ja) | 2002-03-04 | 2005-09-08 | イムクローン システムズ インコーポレイティド | Ｋｄｒに特異的なヒト抗体及びその利用 |
| US20040097711A1 (en) | 2002-03-12 | 2004-05-20 | Henry Yue | Immunoglobulin superfamily proteins |
| EP1394251A1 (en) | 2002-08-23 | 2004-03-03 | Direvo Biotech AG | Method for the selective randomization of polynucleotides |
| JP4436319B2 (ja) | 2002-10-09 | 2010-03-24 | メディジーン リミテッド | 単鎖組換えｔ細胞レセプター |
| EP2336179A1 (en) | 2002-11-08 | 2011-06-22 | Ablynx N.V. | Stabilized single domain antibodies |
| EP2048159B1 (en) | 2002-11-09 | 2014-01-01 | Immunocore Ltd. | T cell receptor display |
| JP2006523437A (ja) | 2002-12-03 | 2006-10-19 | アヴィデックス リミテッド | レセプター複合体 |
| GB0304068D0 (en) | 2003-02-22 | 2003-03-26 | Avidex Ltd | Substances |
| EP1644416A4 (en) * | 2003-06-30 | 2007-08-29 | Centocor Inc | ANTI-TARGET AND GENETICALLY MODIFIED IMMUNOGLOBULIN-DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES |
| WO2005021595A1 (en) | 2003-08-28 | 2005-03-10 | Euro-Celtique S.A. | Methods of antibody engineering using antibody display rules |
| DK1709081T3 (da) * | 2004-01-16 | 2011-06-06 | Regeneron Pharma | Fusionspolypeptider, der kan aktivere receptorer |
| EP1737890A2 (en) | 2004-03-24 | 2007-01-03 | Xencor, Inc. | Immunoglobulin variants outside the fc region |
| US7785903B2 (en) * | 2004-04-09 | 2010-08-31 | Genentech, Inc. | Variable domain library and uses |
| AU2005246073B2 (en) | 2004-05-19 | 2010-10-28 | Adaptimmune Limited | Method of improving T cell receptors |
| NZ550810A (en) | 2004-05-19 | 2009-05-31 | Immunocore Ltd | High affinity NY-ESO T cell receptor |
| GB0411773D0 (en) | 2004-05-26 | 2004-06-30 | Avidex Ltd | Method for the identification of polypeptides which bind to a given peptide mhc complex or cd 1-antigen complex |
| KR20120068807A (ko) | 2004-07-22 | 2012-06-27 | 제넨테크, 인크. | Ｈｅｒ２ 항체 조성물 |
| JP5017116B2 (ja) | 2004-09-24 | 2012-09-05 | アムジエン・インコーポレーテツド | 修飾Ｆｃ分子 |
| CA2582963A1 (en) | 2004-10-01 | 2006-04-13 | Avidex Ltd | T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents |
| WO2007024249A2 (en) | 2004-11-10 | 2007-03-01 | Macrogenics, Inc. | Engineering fc antibody regions to confer effector function |
| US20080274133A1 (en) | 2004-11-18 | 2008-11-06 | Avidex Ltd. | Soluble Bifunctional Proteins |
| GB0425732D0 (en) | 2004-11-23 | 2004-12-22 | Avidex Ltd | Gamma-delta t cell receptors |
| JP4937138B2 (ja) | 2005-01-05 | 2012-05-23 | エフ−シュタール・ビオテヒノロギシェ・フォルシュングス−ウント・エントヴィックルングスゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 相補性決定領域とは異なる分子の領域に設計された結合性を持つ合成免疫グロブリンドメイン |
| GB0503546D0 (en) | 2005-02-21 | 2005-03-30 | Hellenic Pasteur Inst | Antibody |
| US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
| CN101466733A (zh) * | 2006-04-14 | 2009-06-24 | 特鲁比昂药品公司 | 包含免疫球蛋白铰链区和Fc效应子功能改变了的Fc区的结合蛋白 |
| AT503902B1 (de) | 2006-07-05 | 2008-06-15 | F Star Biotech Forsch & Entw | Verfahren zur manipulation von immunglobulinen |
| AT503889B1 (de) | 2006-07-05 | 2011-12-15 | Star Biotechnologische Forschungs Und Entwicklungsges M B H F | Multivalente immunglobuline |
| EP1975178A1 (en) | 2007-03-30 | 2008-10-01 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Transcytotic modular antibody |
| ES2975748T3 (es) | 2007-06-26 | 2024-07-12 | F Star Therapeutics Ltd | Presentación de agentes de unión |
| CN101977932B (zh) | 2008-01-31 | 2014-09-03 | 美国政府健康及人类服务部 | 工程化抗体恒定结构域分子 |
| EP2113255A1 (en) | 2008-05-02 | 2009-11-04 | f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. | Cytotoxic immunoglobulin |
| CN102471375A (zh) | 2009-07-09 | 2012-05-23 | F-斯塔生物技术研究和发展有限公司 | 稳定的免疫球蛋白恒定结构域 |
| US20120010388A1 (en) | 2010-04-16 | 2012-01-12 | Gottfried Himmler | LeY SPECIFIC BIOTHERAPEUTIC |
| EP2407487A1 (en) | 2010-07-14 | 2012-01-18 | F-Star Biotechnologische Forschungs - und Entwicklungsges. M.B.H. | Multispecific modular antibody |
| US20140087957A1 (en) | 2012-09-25 | 2014-03-27 | Marko Vuskovic | Methods, assays and kits for cancer diagnosis and screening utilizing glycan-binding and glycan epitopes |
| GB201317622D0 (en) | 2013-10-04 | 2013-11-20 | Star Biotechnology Ltd F | Cancer biomarkers and uses thereof |
-
2006
- 2006-07-05 AT AT0114706A patent/AT503889B1/de not_active IP Right Cessation
-
2007
- 2007-06-26 JP JP2009516813A patent/JP5924751B2/ja active Active
- 2007-06-26 PL PL11194316T patent/PL2463302T3/pl unknown
- 2007-06-26 SI SI200730848T patent/SI2046831T1/sl unknown
- 2007-06-26 CN CNA200780032991XA patent/CN101522712A/zh active Pending
- 2007-06-26 ES ES11194316.3T patent/ES2539593T3/es active Active
- 2007-06-26 US US12/307,578 patent/US20100048877A1/en not_active Abandoned
- 2007-06-26 CN CN201811561773.1A patent/CN110041430A/zh active Pending
- 2007-06-26 AT AT07718518T patent/ATE540056T1/de active
- 2007-06-26 HU HUE11194316A patent/HUE025035T2/en unknown
- 2007-06-26 EP EP11194316.3A patent/EP2463302B1/en active Active
- 2007-06-26 DK DK07718518.9T patent/DK2046831T3/da active
- 2007-06-26 PL PL07718518T patent/PL2046831T3/pl unknown
- 2007-06-26 DK DK11194316.3T patent/DK2463302T3/da active
- 2007-06-26 EP EP07718518A patent/EP2046831B1/en active Active
- 2007-06-26 PT PT111943163T patent/PT2463302E/pt unknown
- 2007-06-26 PT PT07718518T patent/PT2046831E/pt unknown
- 2007-06-26 WO PCT/AT2007/000313 patent/WO2008003103A2/en active Application Filing
- 2007-06-26 SI SI200731662T patent/SI2463302T1/sl unknown
- 2007-06-26 CN CN201811561771.2A patent/CN110078828A/zh active Pending
- 2007-06-26 ES ES07718518T patent/ES2380127T3/es active Active
-
2013
- 2013-07-11 JP JP2013145770A patent/JP6215603B2/ja active Active
-
2017
- 2017-06-20 JP JP2017120279A patent/JP6681855B2/ja active Active
- 2017-08-15 US US15/677,667 patent/US11827720B2/en active Active
-
2023
- 2023-11-28 US US18/521,492 patent/US20240150495A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2539593T3 (es) | 2015-07-02 |
| EP2463302A1 (en) | 2012-06-13 |
| WO2008003103A3 (en) | 2008-04-17 |
| JP2017163998A (ja) | 2017-09-21 |
| WO2008003103A2 (en) | 2008-01-10 |
| JP5924751B2 (ja) | 2016-05-25 |
| EP2046831A2 (en) | 2009-04-15 |
| EP2046831B1 (en) | 2012-01-04 |
| PL2463302T3 (pl) | 2015-08-31 |
| EP2463302B1 (en) | 2015-04-01 |
| US20240150495A1 (en) | 2024-05-09 |
| US11827720B2 (en) | 2023-11-28 |
| CN110041430A (zh) | 2019-07-23 |
| SI2463302T1 (sl) | 2015-08-31 |
| CN101522712A (zh) | 2009-09-02 |
| JP6681855B2 (ja) | 2020-04-15 |
| JP2013240338A (ja) | 2013-12-05 |
| AT503889A1 (de) | 2008-01-15 |
| US20100048877A1 (en) | 2010-02-25 |
| CN110078828A (zh) | 2019-08-02 |
| JP6215603B2 (ja) | 2017-10-18 |
| AT503889B1 (de) | 2011-12-15 |
| JP2009540837A (ja) | 2009-11-26 |
| US20180051095A1 (en) | 2018-02-22 |
| HUE025035T2 (en) | 2016-01-28 |
| DK2463302T3 (da) | 2015-06-15 |
| ATE540056T1 (de) | 2012-01-15 |
| PL2046831T3 (pl) | 2012-06-29 |
| ES2380127T3 (es) | 2012-05-08 |
| SI2046831T1 (sl) | 2012-03-30 |
| PT2463302E (pt) | 2015-07-21 |
| PT2046831E (pt) | 2012-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2046831T3 (da) | Hidtil ukendte, multivalente immunoglobuliner | |
| ATE513831T1 (de) | Pyridinä3,4-büpyrazinone | |
| FR2909857B1 (fr) | Endovalve. | |
| BRPI0814466A2 (pt) | Método. | |
| ATE469145T1 (de) | 4-ä5-methoxy-6-(2-methyl-6-ä1,2,4ütriazol-1-yl- | |
| CR10161A (es) | Inmunoglobulinas | |
| NL2000537A1 (nl) | Aminederivaten. | |
| BRPI0816970A2 (pt) | 1,3-dissubstituídas-4-fenil-1h-piridin-2-onas | |
| BRPI0807991A2 (pt) | Anticorpos anti-il-23r elaborados. | |
| DK2205562T3 (da) | 1,1,1-trifluor-2-hydroxy-3-phenylpropanderivater | |
| CR10353A (es) | Nuevos compuestos. | |
| DE602007001681D1 (de) | 1,3-dioxan-carboxylsäuren | |
| FI20065446A0 (fi) | Muodostusosa | |
| ATE519751T1 (de) | Dihydro-benzoäbüä1,4üdiazepin-2-on- sulfonamidderivate | |
| ITCE20060002A1 (it) | Patok. | |
| FI20065196A0 (fi) | Muodostusosa | |
| FR2898022B1 (fr) | Parapluie a egouttoir. | |
| ITPA20060003U1 (it) | Bigodino. | |
| ES1062074Y (es) | Autorefrigerante solar-ecologico. | |
| ES1061980Y (es) | Contenedor-palet. | |
| ITPA20060005A1 (it) | Calciocards. | |
| ITPA20060004U1 (it) | Contenitore-dispencer-raccoglitore. | |
| ITSS20060011A1 (it) | Posablocchi. | |
| ITRA20060010A1 (it) | Espositore. | |
| ITPI20060037A1 (it) | Carsy. |